Physiologic Monitoring of Antidepressant Treatment Response
Status:
Completed
Trial end date:
1998-12-01
Target enrollment:
Participant gender:
Summary
Primary: to identify physiologic indicators of venlafaxine treatment response using
quantitative EEG (QEEG) cordance, and to determine if cordance changes are specifically
associated with response to venlafaxine;
Secondary: to determine if cordance changes early in the course (i.e., prior to improvement
in clinical symptoms) of venlafaxine (or another antidepressant if venlafaxine is not
clinically indicated for a particular patient) are predictive of later clinical response.